ABIVAX Société Anonyme (LON:0RA9)
London · Delayed Price · Currency is GBP · Price in EUR 61.70
-2.20 (-3.44%)
At close: Aug 1, 2025
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of 4.03 billion as of August 1, 2025. Its market cap has increased by 574.69% in one year.
Market Cap
4.03B
Enterprise Value
4.03B
Revenue
8.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.70
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 143.21M to 4.03B, an increase of 2,714.11%. That is a compound annual growth rate of 39.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 4.03B | 1,038.19% |
| Dec 31, 2024 | 354.07M | -33.68% |
| Dec 29, 2023 | 533.84M | 480.61% |
| Dec 30, 2022 | 91.95M | -76.57% |
| Dec 31, 2021 | 392.37M | -7.98% |
| Dec 31, 2020 | 426.38M | 89.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 59.04B |
| Haleon | 32.79B |
| Smith & Nephew | 10.24B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.94B |